S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
$0.63
$0.58
$0.38
$1.60
N/A-0.199,151 shs69 shs
Nine Energy Service, Inc. stock logo
NINE
Nine Energy Service
$2.78
-1.4%
$2.27
$1.78
$5.59
$99.62M3.41700,670 shs979,053 shs
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
$5.28
-5.9%
$16.75
$0.70
$3.46
$58.14M1.04648,892 shs653,687 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
0.00%+0.80%+31.28%-40.00%-50.26%
Nine Energy Service, Inc. stock logo
NINE
Nine Energy Service
-1.60%-3.14%+29.67%+18.84%-47.14%
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
-5.88%-9.59%+4.97%+212.43%+254.36%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/AN/AN/AN/AN/AN/AN/AN/A
Nine Energy Service, Inc. stock logo
NINE
Nine Energy Service
0.1653 of 5 stars
0.01.00.00.02.41.70.6
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/AN/AN/AN/A
Nine Energy Service, Inc. stock logo
NINE
Nine Energy Service
1.00
SellN/AN/A
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
$68.45MN/AN/AN/A$6.73 per shareN/A
Nine Energy Service, Inc. stock logo
NINE
Nine Energy Service
$609.53M0.16$0.94 per share2.95($1.01) per share-2.75
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
$250K232.55N/AN/A$0.94 per share5.62

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
-$70.99MN/A0.00N/AN/AN/AN/A4/17/2024 (Estimated)
Nine Energy Service, Inc. stock logo
NINE
Nine Energy Service
-$32.21M-$0.96N/AN/AN/A-5.28%N/A-6.48%5/6/2024 (Confirmed)
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
-$16.41M-$2.80N/AN/A-3,688.31%-202.00%-122.92%N/A

Latest CCM, TROV, and NINE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2024N/A
Nine Energy Service, Inc. stock logo
NINE
Nine Energy Service
-$0.32N/A+$0.32N/AN/AN/A  
3/7/2024Q4 2023
Nine Energy Service, Inc. stock logo
NINE
Nine Energy Service
-$0.35-$0.30+$0.05-$0.30$142.00 million$144.07 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/AN/AN/AN/AN/A
Nine Energy Service, Inc. stock logo
NINE
Nine Energy Service
N/AN/AN/AN/AN/A
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/AN/AN/A
Nine Energy Service, Inc. stock logo
NINE
Nine Energy Service
N/A
2.22
1.56
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
0.12
2.37
2.37

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
N/A
Nine Energy Service, Inc. stock logo
NINE
Nine Energy Service
57.61%
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
9.99%

Insider Ownership

CompanyInsider Ownership
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
46.50%
Nine Energy Service, Inc. stock logo
NINE
Nine Energy Service
5.50%
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
0.60%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Concord Medical Services Holdings Limited stock logo
CCM
Concord Medical Services
918N/AN/ANot Optionable
Nine Energy Service, Inc. stock logo
NINE
Nine Energy Service
1,15735.33 million33.38 millionOptionable
Cardiff Oncology, Inc. stock logo
TROV
Cardiff Oncology
N/A11.01 millionN/ANot Optionable

CCM, TROV, and NINE Headlines

SourceHeadline
Cardiff Oncology shares surge as first-line colorectal cancer study beginsCardiff Oncology shares surge as first-line colorectal cancer study begins
bioworld.com - March 2 at 9:54 AM
Cardiff Oncology Stock (NASDAQ:CRDF) Dividends: History, Yield and DatesCardiff Oncology Stock (NASDAQ:CRDF) Dividends: History, Yield and Dates
benzinga.com - February 23 at 8:35 AM
Cardiff Oncology’s Onvansertib Shows Promise: An Analysis of the Buy Rating RecommendationCardiff Oncology’s Onvansertib Shows Promise: An Analysis of the Buy Rating Recommendation
markets.businessinsider.com - September 29 at 7:51 AM
Stocks to Watch: MillerKnoll, Cardiff Oncology, Morphic HoldingsStocks to Watch: MillerKnoll, Cardiff Oncology, Morphic Holdings
marketwatch.com - September 26 at 8:02 PM
Cardiff Oncology Shares Up 26% After Potential Cancer Treatment AdvancesCardiff Oncology Shares Up 26% After Potential Cancer Treatment Advances
marketwatch.com - August 8 at 1:26 PM
H.C. Wainwright Sticks to Their Buy Rating for Cardiff Oncology (CRDF)H.C. Wainwright Sticks to Their Buy Rating for Cardiff Oncology (CRDF)
markets.businessinsider.com - August 8 at 8:26 AM
Cardiff Oncology (NASDAQ: CRDF)Cardiff Oncology (NASDAQ: CRDF)
fool.com - May 27 at 10:27 PM
Cheap Flights from Cardiff to BordeauxCheap Flights from Cardiff to Bordeaux
skyscanner.net - May 15 at 10:11 AM
Cheap Flights from Cardiff to CorkCheap Flights from Cardiff to Cork
skyscanner.net - May 2 at 5:42 PM
Cardiff City FCCardiff City FC
walesonline.co.uk - April 29 at 12:09 AM
Benetton 27-23 Cardiff: Welsh sides Challenge Cup over after tight affair in ItalyBenetton 27-23 Cardiff: Welsh side's Challenge Cup over after tight affair in Italy
walesonline.co.uk - April 25 at 1:30 PM
Cardiff OncologyCardiff Oncology
forbes.com - January 13 at 4:28 PM
Cardiff hostel plagued by drug users and anti-social behaviour goes up for saleCardiff hostel plagued by drug users and anti-social behaviour goes up for sale
walesonline.co.uk - January 11 at 3:27 PM
Christmas tree collection dates in CardiffChristmas tree collection dates in Cardiff
walesonline.co.uk - January 11 at 3:27 PM
As Onvansertib fumarate moves closer to clinical approval, what is the likelihood that the drug will be approved?As Onvansertib fumarate moves closer to clinical approval, what is the likelihood that the drug will be approved?
pharmaceutical-technology.com - January 4 at 6:32 AM
Cardiff Oncology: Staying The CourseCardiff Oncology: Staying The Course
seekingalpha.com - December 14 at 9:58 AM
Cardiff Oncology Reports Third Quarter 2022 Results and Provides Business UpdatesCardiff Oncology Reports Third Quarter 2022 Results and Provides Business Updates
fbherald.com - November 4 at 5:22 AM
Clear Channel Outdoor And 2 Other Penny Stocks Insiders Are Aggressively BuyingClear Channel Outdoor And 2 Other Penny Stocks Insiders Are Aggressively Buying
markets.businessinsider.com - October 16 at 3:13 PM
Cardiff Oncology, Inc. (CRDF)Cardiff Oncology, Inc. (CRDF)
finance.yahoo.com - September 29 at 6:59 PM
CRDF Cardiff Oncology, Inc.CRDF Cardiff Oncology, Inc.
seekingalpha.com - September 24 at 9:47 AM
Cardiff drops its lead prostate can­cer pro­gram, send­ing shares in­to a tail­spinCardiff drops its lead prostate can­cer pro­gram, send­ing shares in­to a tail­spin
endpts.com - September 15 at 6:24 PM
Looking Into Cardiff Oncologys Return On Capital EmployedLooking Into Cardiff Oncology's Return On Capital Employed
msn.com - August 25 at 1:45 AM
Cardiff Oncology: Down But Not OutCardiff Oncology: Down But Not Out
seekingalpha.com - August 22 at 7:24 PM
Cardiff Oncology (CRDF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Cardiff Oncology (CRDF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
finance.yahoo.com - July 28 at 1:28 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Concord Medical Services logo

Concord Medical Services

NYSE:CCM
Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, head gamma knife system, and diagnostic imaging services. The company's other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. The company was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
Nine Energy Service logo

Nine Energy Service

NYSE:NINE
Nine Energy Service, Inc. operates as an onshore completion services provider that targets unconventional oil and gas resource development in North American basins and internationally. It offers cementing services, including blending high-grade cement and water with various solid and liquid additives to create a cement slurry that is pumped between the casing and the wellbore of the well. The company also provides open hole and cemented completion tool products, such as liner hangers and accessories, fracture isolation packers, frac sleeves, stage one prep tools, casing flotation tools, specialty open hole float equipment, disk subs, composite cement retainers, and centralizers that provide pinpoint frac sleeve system technologies. In addition, it offers wireline services consisting of plug-and-perf completions, which is a multistage well completion technique for cased-hole wells that consists of deploying perforating guns and isolation tools to a specified depth; and coiled tubing services, which perform wellbore intervention operations utilizing a continuous steel pipe that is transported to the wellsite wound on a large spool. The company was formerly known as NSC-Tripoint, Inc. and changed its name to Nine Energy Service, Inc. in October 2011. Nine Energy Service, Inc. was incorporated in 2011 and is headquartered in Houston, Texas.
Cardiff Oncology logo

Cardiff Oncology

NASDAQ:TROV
Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan in 1999 and is headquartered in San Diego, CA.